Gullaksen S, Vernstrm L, Srensen SS et al (2023) Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: a prespecified secondary analysis of a randomised clinical trial
Kidney Function Tests Tests: Serum creatinine Estimated glomerular filtration rate (eGFR) Blood urea nitrogen (BUN) Why It Matters: GLP-1 medications are associated with: Reduced appetite lower fluid intake Gastrointestinal side effects (e.g., nausea, vomiting) These factors increase the risk of dehydration, which can compromise renal functionparticularly in patients with pre-existing impairment
It is not unusual to experience side effects when beginning a new medication or increasing the dosage
excessive protein can lead to unnecessary calorie consumption
following a diabetes-friendly diet is extremely important to control blood sugar levels and lose weight on tirzepatide or other diabetes drugs
The March 2026 Peptide Sciences shutdown, the 40-state-AG letter, and new telehealth rules close the gray zone fast
